Back

Metformin reduces the risk of poor treatment outcomes among individuals with rifampicin-resistant tuberculosis and type-2 diabetes mellitus

Salindri, A. D.; Gujabidze, M.; Kipiani, M.; Lomtadze, N.; Tukvadze, N.; Avaliani, Z.; Blumberg, H. M.; Kornfeld, H.; Kempker, R. R.; Magee, M. J.

2024-07-14 infectious diseases Community evaluation
10.1101/2024.07.12.24310348 medRxiv
Show abstract

We conducted a retrospective cohort study among individuals with rifampicin-resistant tuberculosis and diabetes to determine the association between metformin use and tuberculosis treatment outcomes. We found that individuals with metformin use had a significantly lower risk of poor tuberculosis treatment outcomes (adjusted RR=0.25, 95%CI 0.06 - 0.95) compared to those without.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.